Advertisement

Topics

Joint 24th Medicines for Europe and 21st IGBA Annual Conference – Global Generic, Biosimilar and Value Added Medicines Conference

04:02 EST 9 Mar 2018 | Generics and Biosimilars Initiative

Joint 24th Medicines for Europe and 21st IGBA Annual Conference – Global Generic, Biosimilar and Value Added Medicines Conference
13−15 June 2018
Hilton Budapest Hotel
Budapest
Hungary

Original Article: Joint 24th Medicines for Europe and 21st IGBA Annual Conference – Global Generic, Biosimilar and Value Added Medicines Conference

NEXT ARTICLE

More From BioPortfolio on "Joint 24th Medicines for Europe and 21st IGBA Annual Conference – Global Generic, Biosimilar and Value Added Medicines Conference"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Rheumatology
Arthritis Fibromyalgia Gout Lupus Rheumatic Rheumatology is the medical specialty concerned with the diagnosis and management of disease involving joints, tendons, muscles, ligaments and associated structures (Oxford Medical Diction...

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...

Biosimilars
Biosimilars or Follow-on biologics are terms used to describe officially approved subsequent versions of innovator biopharmaceutical products made by a different sponsor following patent and exclusivity expiry on the innovator product. Products that ar...